Abstract |
|
Authors | A Blank, A Eidam, M Haag, N Hohmann, J Burhenne, M Schwab, Sfj van de Graaf, M R Meyer, H H Maurer, K Meier, J Weiss, T Bruckner, A Alexandrov, S Urban, G Mikus, W E Haefeli |
Journal | Clinical pharmacology and therapeutics
(Clin Pharmacol Ther)
Vol. 103
Issue 2
Pg. 341-348
(02 2018)
ISSN: 1532-6535 [Electronic] United States |
PMID | 28543042
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017 American Society for Clinical Pharmacology and Therapeutics. |
Chemical References |
- Antiviral Agents
- Bile Acids and Salts
- Biomarkers
- Lipopeptides
- Organic Anion Transporters, Sodium-Dependent
- Reverse Transcriptase Inhibitors
- Symporters
- myrcludex-B
- sodium-bile acid cotransporter
- Tenofovir
- CYP3A protein, human
- Cytochrome P-450 CYP3A
|
Topics |
- Administration, Oral
- Adult
- Antiviral Agents
(administration & dosage, adverse effects, pharmacokinetics)
- Bile Acids and Salts
(blood)
- Biomarkers
(blood)
- Cytochrome P-450 CYP3A
(metabolism)
- Drug Interactions
- Female
- Humans
- Injections, Subcutaneous
- Lipopeptides
(administration & dosage, adverse effects, pharmacokinetics)
- Male
- Middle Aged
- Organic Anion Transporters, Sodium-Dependent
(antagonists & inhibitors, metabolism)
- Prospective Studies
- Reverse Transcriptase Inhibitors
(administration & dosage, adverse effects, pharmacokinetics)
- Risk Assessment
- Symporters
(antagonists & inhibitors, metabolism)
- Tenofovir
(administration & dosage, adverse effects, pharmacokinetics)
- Up-Regulation
- Young Adult
|